~" Cell proliferation potential was assessed by measuring the labeling indices of the monoclonal antibody Ki-67 and of 5-bromodeoxyuridine (BUdR), and the cellular deoxyribonucleic acid (DNA) content in 48 human brain tumors. The diagnostic and prognostic value of flow-cytometric DNA analysis was also evaluated using ethanol-fixed paraffin-embedded BUdR-labeled specimens; these were the same specimens as were used for measuring the BUdR and Ki-67 labeling indices. Both the Ki-67 and the BUdR labeling indices correlated with the degree of malignancy estimated from conventional histological preparations. The Ki-67 labeling index was 1.7 times greater than the BUdR labeling index. The relationship of DNA aneuploidy to the labeling indices or to morphology in cases of glioma was examined. All of the tumors with an aneuploid line corresponded to malignant glioma classified by histological criteria, although malignant glioma did not always show DNA aneuploidy. In addition, the cases with aneuploid lines showed high BUdR and Ki-67 labeling indices. The cell kinetic data, which indicate the biological character of tumors, allowed prediction of the prognosis of the patients with gliomas. In contrast, despite the presence of an aneuploid line, three of 13 meningiomas showed a benign histological pattern without an aggressive clinical course, and neither the Ki-67 nor the BUdR labeling index was high. These results indicate an unequivocal relationship between DNA aneuploidy and clinical behavior; in general, both labeling indices may prove to be objective indicators of the outcome of patients with brain tumors.
T HE development of flow cytometry has facilitated deoxyribonucleic acid (DNA) analysis of human tumors in terms of karyotypic abnormalities. The measurement of tumor DNA content has been considered valuable in predicting the prognosis of patients, and many studies of DNA aneuploidy in brain tumors have been reported. 34"~2-14-16 However, the clinical correlations of aneuploidy in brain tumors remain controversial. Some investigators have claimed that malignant brain tumors are frequently associated with DNA aneuploidy. ~ -~" ~ 4. ~ 6 In contrast, Mork and Laerum ~ ~ reported no relationship between heteroploidy of tumor cells and their clinical/biological behavior. Some authors have related aneuploidy to favorable prognosis in patients with neuroblastoma or medulloblastoma.5-~7, 28 Hoshino and coworkers ~2 reported regional differences in the DNA index within the same tumor, especially in human gliomas, although correlation between DNA ploidy and morphological appearance could be demonstrated. The relationship of DNA ploidy to histological features needs to be examined in the same tumor block. The sophisticated method developed by Hedley, et al.,~~ ~ facilitated flow-cytometric DNA analysis of paraffin-embedded materials, allowing extensive retrospective studies.
Other useful and reliable markers for assessing proliferative activity include the labeling indices of the monoclonal antibody Ki-676"7 and of 5-bromodeoxyuridine (BUdR); 2"9"13"19-22"26 these indices can be determined from histological preparations. There have been no precise studies involving estimation of aneuploidy in relation to immunohistochemical cell kinetics. In this communication, the measurement of these two labeling indices in human brain tumors and DNA analysis in the same block of tumor tissue as that employed for histological preparations is reported. The correlations existing among cell kinetic parameters are discussed.
Materials and Methods
Ethanol-fixed paraffin-embedded specimens of hum a n brain tumors were prepared as previously described, using surgically extirpated tumor tissue that had been treated with BUdR. 22"26 Briefly, the excised t u m o r tissues were cut into l-cu m m fragments and incubated in an airtight 5-ml vial containing 3 ml of R P M I 1640 medium and 20% fetal bovine serum, along with 100 #g of BUdR. Carbogen (3 atm) was added in order to promote penetration of BUdR into the tissue fragments. After incubation at 37"C for 1 hour, each fragment was washed with phosphate-buffered saline, fixed in cold 70% ethanol for 3 hours, and embedded in paraffin. Flow-cytometric D N A analyses of these materials were conducted on serial sections adjacent to sections stained with hematoxylin and eosin (H & E) and antiBUdR monoclonal antibody. The sections were prepared according to the method of Schutte, et al. 27 Five or six 40-~m sections were cut from paraffin-embedded blocks using a microtome and were deparaffinized by submersion in two changes of xylene for 2 hours each at room temperature. They were then rehydrated in a series of 100%, 100%, 95%, 70%, and 50% ethanol for 2 hours each at room temperature. The specimens were incubated overnight at 37"C in 0.25% trypsin solution in buffer (3 m M trisodium citrate, 0.1% vol/vol Nonidet P40, 1.5 m M spermine tetrahydrochloride, 0.5 m M Tris, pH 7.6). After the solution was filtered through a 40-/~m nylon mesh, propidium iodide containing spermine tetrahydrochloride was added and the mixture was kept in an ice-cold box.
Fluorescence, emitted at 630 nm from propidium iodide-containing D N A in the cell nuclei, was measured with a flow cytometer.* This study did not include specimens in which the D N A histogram showed less than a 10% coefficient of variance or for which H & E staining revealed excessively small populations of tumor cells compared with normal or gliomatous cells.
In addition to BUdR, staining of the Ki-67 monoclonal antibodyt was performed on frozen sections. These sections were reacted with Ki-67 and BUdR monoclonal antibody for l hour each at room temperature. This was followed by reaction with biotinylated goat anti-mouse immunoglobulin for 30 minutes and treatment with peroxidase-conjugated streptavidine for 30 minutes. The sections were then reacted with 20 mg * Flow cytometer, Model EPICS 753, manufactured by Coulter Electronics, Inc., Hialeah, Florida.
~" Monoclonal antibody supplied by DAKO Corp., Santa Barbara, California. of diaminobenzidine tetrahydrochloride and Tris-HC1 buffer containing H_~O2 for l0 minutes. Hematoxylin was used to counterstain the tissue sections. The degree of proliferative activity was estimated by determining the number of cells positive for Ki-67 and BUdR, and was expressed as a percentage of the total number of cells scored at a magnification of • 400 at more than three sites where the numbers of Ki-67-and BUdRpositive cells were relatively high.
Results
The labeling indices of 48 brain tumors are summarized in Table 1 . The values of the Ki-67 labeling index paralleled the degree of histological malignancy. The Ki-67 labeling indices were higher than BUdR labeling indices in all except two cases in this series, and on the average the former was 1.7 times higher than the latter. An aneuploid line was clearly found in these 48 cases of brain tumor, although the mean coefficient of variance for flow-cytometric DNA measurements was 7.3%. Tumors with aneuploidy showed high values for both labeling indices, with a few exceptions (Fig. 1) . In gliomas, a correlation among the three parameters of DNA aneuploidy, histological grade, and the values of both labeling indices was evident (Fig. 2) .
Histologically, ghomas with DNA aneuploidy revealed high-grade malignancy, although not all the ship between DNA ploidy and either histological characteristics or proliferative activity estimated from the labeling indices (Figs. 3 and 4) . Aneuploidy was seen with the same frequency in both differentiated and malignant meningiomas. Even when the labeling indices were below 1%, aneuploidy was found in three cases of meningioma. In three cases of primitive neuroectodermal tumor, favorable and unfavorable prognoses were identified in aneuploid and diploid tumors, respectively.
Discussion

Several authors have reported on a method for performing immunohistochemical ceU kinetics studies using B U d R . 2'')'~3"~-21
We have adapted this approach for brain tumors 22 (according to the method described by Sasaki, et a/. 26) since it seemed to be simple, safe, and reproducible as compared to the intravenous infusion method. Recently, another monoclonal antibody, Ki-67, which recognizes a human nuclear antigen that is present in the Gt, S, G2, and M phases of the cell cycle but absent in the Go phase and some part of the S phase, has been used for analysis of various types of tumorJ '7 Since then, Ki-67 has been put to practical use in cases of human brain tumor. Giangaspero, et al.fl claimed that, in Ki-67 staining, the period between removal of the specimen and freezing must be less than 30 minutes. In our experiments, Ki-67 labeling exceeded that of BUdR labeling indices in tumor tissues frozen within 1 hour after removal. In two autopsy cases, however, the relationship between the two labeling indices was reversed. This may be due to rapid degradation of the Ki-67-reactive antigen, because in both cases a long time elapsed until removal of the tumor specimen.
Regional differences in DNA histogram patterns and histological features are not infrequent in human gliomas ~2 and gastrointestinal carcinomas, z* Consequently, the relationship between DNA ploidy and histological characteristics should be evaluated in the same tissue fragment, although a close relationship between morphological appearance or clinical features and DNA ploidy has been reported. ~'7"28 Therefore, using paraffin-embedded specimens, the relationship of DNA aneuploidy to cell kinetic data obtained by the immunological study method was examined in serial sections.
In gliomas, all nine cases showing aneuploidy demonstrated high labeling indices for BUdR and Ki-67 antibodies; seven of these were classified as glioblastoma multiforme and two as anaplastic astrocytoma. In contrast, most of the gliomas without DNA aneuploidy showed low labeling indices, although some of them were considered malignant on the basis of their histological features. One of the reasons why opposite results were obtained might have been the heterogeneity of the cell populations composing the tumor. When DNA diploid cells are predominant, it may be difficult to detect aneuploid lines. It is therefore important to reduce the coefficient of variance in DNA histograms. However, it is technically difficult to obtain histograms with a small coefficient of variance in experiments using paraffin-embedded specimens. Although an absence of aneuploidy did not always indicate the benign nature of a tumor, DNA analysis provided useful information as well as the labeling indices in this group of gliomas. In contrast, Look, et al., j7 and Gansler, et aL, 5 disclosed that patients with aneuploid neuroblastomas had a favorable prognosis compared with patients suffering from diploid tumor. Tomita and his colleagues 28 reported the same results in medulloblastoma. We observed no correlation between DNA ploidy and labeling indices in undifferentiated brain tumors, but no definite conclusion could be drawn because of the small number of cases examined. However, the prognosis of the patient with diploid tumor (Case 34) was extremely poor and he died of high intracranial pressure within 1 year after onset of the presenting symptom; in contrast, the patient with aneuploid tumor (Case 33) lived for 7 years after onset. In undifferentiated brain tumors, DNA ploidy may thus provide clinically useful information, but the interpretation must be different from that of glioma.
Four of 13 cases of meningioma showed an aneuploid cell line. In three of four aneuploid cases, the histological features were benign and the values of their labeling indices were low, but the fourth case was a malignant meningioma. In any event, DNA histograms from cases of glioma, meningioma, and undifferentiated tumor should be evaluated on different bases.
